Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 -0.02 (-5.09%)
As of: Oct 21, 2026 · 3:59 PM EDT

Citius Pharmaceuticals (CTXR) Non-Current Deferred Tax Liability (2019 - 2026)

Updated

Citius Pharmaceuticals' Non-Current Deferred Tax Liability came in at $7.7 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 2.5% from $7.51 million a year earlier but down 1.4% from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals' Non-Current Deferred Tax Liability was $7.77 million, up 15.7% from FY2024.

  • Non-Current Deferred Tax Liability has increased in each of the last four fiscal years, with a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
  • Going back by fiscal year, Non-Current Deferred Tax Liability was $6.71 million in FY2024 (+9.4%), $6.14 million in FY2023 (+10.4%), $5.56 million in FY2022 (+11.6%) and $4.99 million in FY2021 (unchanged).
  • The five-year range for quarterly Non-Current Deferred Tax Liability is $4.99 million (fiscal Q4 2021) to $8.04 million (fiscal Q1 2026).
  • Year-over-year, Non-Current Deferred Tax Liability has increased for 16 consecutive quarters, with growth averaging 11.1% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Non-Current Deferred Tax Liability ranged from 0.0% (fiscal Q4 2021) to 20.2% (fiscal Q3 2023).
  • Business Quant data shows CTXR's Non-Current Deferred Tax Liability at $7.8 million (Q2 2026), $8.04 million (Q1 2026) and $7.77 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Citius Pharmaceuticals 10.37 Mn -23.20 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.70 Mn
Mar 31, 2026 7.80 Mn
Dec 31, 2025 8.04 Mn
Sep 30, 2025 7.77 Mn
Jun 30, 2025 7.51 Mn
Mar 31, 2025 7.24 Mn
Dec 31, 2024 6.98 Mn
Sep 30, 2024 6.71 Mn
Jun 30, 2024 6.57 Mn
Mar 31, 2024 6.43 Mn
Dec 31, 2023 6.28 Mn
Sep 30, 2023 6.14 Mn
Jun 30, 2023 5.99 Mn
Mar 31, 2023 5.85 Mn
Dec 31, 2022 5.71 Mn
Sep 30, 2022 5.56 Mn
Jun 30, 2022 4.99 Mn
Mar 31, 2022 4.99 Mn
Dec 31, 2021 4.99 Mn
Sep 30, 2021 4.99 Mn
API Access

Citius Pharmaceuticals Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=CTXR&period=max&api_key=YOUR_API_KEY